Developing the Revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors
- 1 January 2002
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (15) , 1031-1038
- https://doi.org/10.2165/00019053-200220150-00001
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Health Economic Guidelines—Similarities, Differences and Some ImplicationsValue in Health, 2001
- Pharmaceutical Regulation: The Early Experience of the NHS National Institute for Clinical Excellence (NICE) Appraisal Process—Where Are We Headed? Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000Value in Health, 2001
- Problems With the Interpretation of Pharmacoeconomic AnalysesJAMA, 2000
- Use of economic evaluation guidelines: 2 years’ experience in CanadaHealth Economics, 1998
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Canadian Guidelines for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1996
- The Canadian “Model” for the Establishment of GuidelinesDrug Information Journal, 1996